From code to cure: Harnessing AI for antibiotic discovery and design
Science Translational Medicine · 2026-10-14 · 18 (871)
DOI: 10.1126/scitranslmed.aee4629 ↗Abstract
Artificial intelligence (AI) now enables the exploration of vast chemical and sequence spaces, the design of synthesizable antibiotics, and the prioritization of safe, mechanism-diverse candidates through integrated modeling and accelerated testing. Here, we survey recent advances in AI for both small-molecule and peptide antimicrobial drugs, highlight emerging data and reporting standards, and outline translational pathways and regulatory hurdles needed to bring these agents to patients.
EUVIMED